evidence_review
NMN Dosage by Body Weight (mg/kg): Why the Math Is Wrong
NMN per-kg calculators are extrapolated from mouse studies. Human trials used flat 250–1250 mg doses, not mg/kg — why weight-based NMN dosing misleads.
last_updated=
- published
- read_time
- 4 min
- refs
- 10
section_index
editorial_pick
CoreAge Rx
From $93/mo
Doctor-reviewed NAD+ at the lowest published price here, with human support included.
Check availabilityAffiliate link · we may earn a commission, at no extra cost to you.
also_offering_nad
RxSpan MD
Physician-led NAD+ & longevity telehealth
See RxSpan MDSearch for "NMN dosage by body weight" and you'll find calculators promising a personalized milligrams-per-kilogram number — take your weight, multiply by some per-kg figure, and out comes "your" dose. It feels rigorous and scientific. It is, unfortunately, built on a basic error: those per-kg numbers are reverse-engineered from mouse studies, and they cannot be honestly scaled to a human body by simple multiplication. The actual human NMN trials never dosed by weight at all — they used flat doses, almost always in the 250–1,250 mg/day range, regardless of how much the participant weighed.
This page explains where the mg/kg numbers come from, why the mouse-to-human conversion that underlies them is wrong, and what the real human dose-finding studies actually used — so you can ignore the weight-based calculators with confidence.
Where the "mg/kg" numbers actually come from
The per-kilogram figures floating around supplement forums trace back to the famous mouse longevity work. In the landmark long-term study, mice were given NMN in their drinking water at roughly 100–300 mg/kg/day and showed mitigation of age-related physiological decline 1. Someone then took that mouse mg/kg number and multiplied it by a human's body weight — for example, "300 mg/kg × 70 kg = 21,000 mg" — and either used it directly or scaled it down by a hand-wavy factor. Both approaches are wrong, because the dose a mouse needs per kilogram is not the dose a human needs per kilogram.
// Mouse dose vs human reality
| // Method | How it scales | Implied dose |
|---|---|---|
| Naive mg/kg calculator | Mouse ~300 mg/kg × your body weight | ~21,000 mg (70 kg) — over 10× too high |
| Correct surface-area conversion | Mouse mg/kg ÷ ~12.3 (HED factor) | ~24 mg/kg ≈ ~1,700 mg (70 kg) |
| What human trials actually used | Flat dose, NOT by body weight | 250 mg/day typical; up to 1,250 mg single dose |
Why mouse-to-human mg/kg doesn't transfer
The reason is metabolic-rate scaling, and it's textbook pharmacology, not a fringe objection. Small animals have a far higher metabolic rate per kilogram of body weight than large animals, so they clear and use drugs faster per kilogram. To convert an animal dose to a human-equivalent dose (HED), pharmacologists don't multiply by body weight — they divide by a species-specific scaling factor based on body-surface area. The standard guide assigns mice a conversion factor of about 12.3, meaning a mouse mg/kg dose must be divided by roughly 12 to estimate the human-equivalent mg/kg, not used as-is 2.
Run the real math and the "calculator" doses collapse. A 300 mg/kg mouse dose converts to roughly 24 mg/kg human-equivalent (300 ÷ 12.3) — about 1,700 mg for a 70 kg person, in the same ballpark as the flat doses humans were actually given. The naive "300 mg/kg × your weight" version overshoots by more than ten-fold. So the mg/kg calculators aren't just imprecise; the simple ones are off by an order of magnitude in the dangerous direction. (For practical, evidence-based dosing instead of this flawed arithmetic, see our NAD+ and NMN dosage guide.)
What the human NMN trials actually used: flat doses
Here's the decisive point the calculators ignore: no published human NMN trial dosed participants by body weight. Every one used a fixed flat dose. Walking through them makes the real-world range obvious:
- A single-dose study in healthy men tested 100, 250, and 500 mg and found even 500 mg was safely metabolized 3.
- The widely cited metabolic trial gave prediabetic women 250 mg/day 4.
- Studies in older adults used 250 mg/day for 12 weeks and reported elevated blood NAD+ with effects on muscle function, walking speed, and sleep 567.
- A randomized dose-finding trial in middle-aged adults compared 300, 600, and 900 mg/day 8.
- A safety study established that a single dose as high as 1,250 mg was well tolerated 9.
// Human NMN trial doses
| // Trial population | Flat dose used | Note |
|---|---|---|
| Healthy men (single dose) | 100 / 250 / 500 mg | Even 500 mg safely metabolized |
| Prediabetic women | 250 mg/day | Raised insulin sensitivity marker |
| Older adults (12 wk) | 250 mg/day | Raised NAD+; muscle / walking / sleep effects |
| Middle-aged adults | 300 / 600 / 900 mg/day | Dose-finding; NAD+ rise plateaus |
| Healthy adults (safety) | 1,250 mg single dose | Well tolerated — far above 250 mg |
A 60 kg woman and a 100 kg man in these trials received the same 250 mg — and both raised their blood NAD+. That is the opposite of how a weight-based drug is dosed, and it tells you the field simply does not treat NMN as an mg/kg compound.
Why flat dosing is actually defensible here
This isn't sloppiness on the researchers' part. NMN's measurable effect — raising blood NAD+ — appears to plateau: across these trials, going from 250 mg to higher doses produced diminishing additional increases in NAD+, not a clean dose-proportional climb. When a supplement's biomarker saturates, fine-tuning the milligrams to someone's body weight buys little, which is exactly why the trials standardized on round flat numbers. It's also worth remembering that "raises blood NAD+" is itself a long way from "delivers a health benefit" — NAD+ rises reliably in these studies while functional benefits remain modest and inconsistent — so chasing a precision-dose by weight optimizes a number that may not translate to how you feel anyway. NAD+ does decline with age and metabolic stress 10, which is the rationale for supplementing at all, but that rationale doesn't resurrect mg/kg dosing.
The honest bottom line on NMN dosing by weight
- The mg/kg calculators are extrapolated from mouse studies 1 and rely on a mouse-to-human conversion that is mathematically wrong — animal doses must be scaled down by a surface-area factor (÷~12 for mice), not multiplied by your weight 2.
- No human NMN trial dosed by body weight. They used flat doses, overwhelmingly 250 mg/day, up to single doses of 1,250 mg 3456789.
- Because NMN's NAD+ effect plateaus, body-weight precision buys little — and the felt benefit of raising NAD+ is itself uncertain.
If you're choosing a dose, ignore the per-kg calculators and anchor to what was actually studied in people: most evidence sits at 250 mg/day, with safety demonstrated well above that. Our own NMN dosage calculator shows you the flat evidence-based dose and demonstrates, with your own weight, exactly how far the per-kg math overshoots. For a fuller breakdown, see our NAD+ and NMN dosage guide; to pick a product at a sensible dose and verified purity, see our best NMN supplements rankings and the absorption question in sublingual NMN vs capsules. And for the broader question of whether any of this delivers, start with our NAD+ therapy evidence pillar and the NAD+ rankings hub.
Frequently asked questions
How much NMN should I take based on my body weight?
You shouldn't dose NMN by body weight. No published human NMN trial used a milligrams-per-kilogram dose — they all used flat doses, most commonly 250 mg/day, with single doses up to 1,250 mg shown to be safe. The mg/kg calculators online are extrapolated from mouse studies and rely on a conversion that is mathematically wrong, so they don't give you a more 'personalized' or accurate dose.
Why are NMN mg/kg calculators wrong?
They take a mouse dose (around 100–300 mg/kg in the longevity studies) and multiply it by your body weight, which overshoots the real human-equivalent dose by more than ten-fold. Correct pharmacology scales animal doses down by a body-surface-area factor — roughly dividing a mouse mg/kg dose by 12 — because small animals have a much higher metabolic rate per kilogram. After that correction, the mouse dose lands near the same flat doses humans actually take.
Does a heavier person need more NMN?
The human trials suggest not in a simple proportional way. NMN's main measurable effect — raising blood NAD+ — tends to plateau, so going higher produces diminishing additional increases rather than a dose-proportional climb. In the studies, a lighter and a heavier participant received the same flat dose (often 250 mg) and both raised their NAD+. Body-weight precision buys little, which is why researchers standardized on flat doses.
What is the most evidence-based NMN dose?
Most human evidence sits at 250 mg/day, which raised blood NAD+ and showed modest effects on muscle function, walking speed, and sleep in older adults, with safety demonstrated well above that level (single doses up to 1,250 mg were well tolerated). Keep in mind that raising NAD+ is not the same as a guaranteed health benefit — the felt effects in trials are modest and inconsistent — so there's little reason to chase a high or weight-based dose.
References
- Mills KF, Yoshida S, Stein LR, et al. (2016). Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metabolism. https://pubmed.ncbi.nlm.nih.gov/28068222/
- Nair AB, Jacob S (2016). A simple practice guide for dose conversion between animals and human. Journal of Basic and Clinical Pharmacy. https://pubmed.ncbi.nlm.nih.gov/27057123/
- Irie J, Inagaki E, Fujita M, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal. https://pubmed.ncbi.nlm.nih.gov/31685720/
- Yoshino M, Yoshino J, Kayser BD, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. https://pubmed.ncbi.nlm.nih.gov/33888596/
- Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Aging. https://pubmed.ncbi.nlm.nih.gov/35927255/
- Kim M, Seol J, Sato T, et al. (2022). Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study. Nutrients. https://pubmed.ncbi.nlm.nih.gov/35215405/
- Morifuji M, Higashi S, Ebihara S, Nagata M (2024). Ingestion of β-nicotinamide mononucleotide increased blood NAD levels, maintained walking speed, and improved sleep quality in older adults in a double-blind randomized, placebo-controlled study. GeroScience. https://pubmed.ncbi.nlm.nih.gov/38789831/
- Yi L, Maier AB, Tao R, et al. (2023). The efficacy and safety of β-nicotinamide mononucleotide (NMN) supplementation in healthy middle-aged adults: a randomized, multicenter, double-blind, placebo-controlled, parallel-group, dose-dependent clinical trial. GeroScience. https://pubmed.ncbi.nlm.nih.gov/36482258/
- Fukamizu Y, Uchida Y, Shigekawa A, et al. (2022). Safety evaluation of β-nicotinamide mononucleotide oral administration in healthy adult men and women. Scientific Reports. https://pubmed.ncbi.nlm.nih.gov/36002548/
- Covarrubias AJ, Perrone R, Grozio A, Verdin E (2021). NAD+ metabolism and its roles in cellular processes during ageing. Nature Reviews Molecular Cell Biology. https://pubmed.ncbi.nlm.nih.gov/33353981/
Medical disclaimer: This content is for general educational purposes only and is not medical advice, diagnosis, or treatment. Always consult a licensed healthcare professional before starting, stopping, or changing any treatment.
continue_reading
Nicotinamide Riboside (NR) Dosage: What the Trials Used
Nicotinamide riboside (NR) has real human RCT dosing — trials used ~250–1000 mg/day. What the studies actually used, and why more isn't proven better.
ReadNMN Side Effects: What the Human Studies Actually Show
NMN was well tolerated in short human trials — mostly mild GI effects, no serious signal — but long-term safety is genuinely unestablished. The honest picture.
ReadNAD+ Dosage Guide: How Much Per Day, by Form and Route
What the human trials actually used for NR, NMN, niacin and nicotinamide — plus why the tidy injection and IV dosage charts online have no trial behind them.
ReadNMN vs NR: What the Human Trials Show
NMN and NR both raise NAD+ — but how do their human trials compare on insulin sensitivity, walking, sleep, cognition, and safety?
ReadNMN for Fertility and Egg Quality: What the Evidence Shows
NMN and NAD+ are marketed for egg quality and fertility. The mouse data are striking — but the human evidence is essentially absent. An honest review.
ReadDoes NAD+ Actually Boost Energy?
NAD+ powers cellular energy metabolism — but does supplementing it make you feel more energetic? The honest answer from human trials.
Read